Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells.
Saved in:
| Title: | Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells. |
|---|---|
| Authors: | Cartwright ANR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Suo S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Badrinath S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Kumar S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Melms J; Columbia Center for Translational Immunology, New York, New York.; Columbia University Medical Center, Division of Hematology and Oncology, New York, New York., Luoma A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Bagati A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Saadatpour A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Izar B; Columbia Center for Translational Immunology, New York, New York.; Columbia University Medical Center, Division of Hematology and Oncology, New York, New York., Yuan GC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. kai_wucherpfennig@dfci.harvard.edu.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2021 Apr; Vol. 9 (4), pp. 470-485. Date of Electronic Publication: 2021 Jan 29. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33514509 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8<superscript>+</superscript> T Cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cartwright+ANR%22">Cartwright ANR</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Suo+S%22">Suo S</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Badrinath+S%22">Badrinath S</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Melms+J%22">Melms J</searchLink>; Columbia Center for Translational Immunology, New York, New York.; Columbia University Medical Center, Division of Hematology and Oncology, New York, New York.<br /><searchLink fieldCode="AU" term="%22Luoma+A%22">Luoma A</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bagati+A%22">Bagati A</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Saadatpour+A%22">Saadatpour A</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Izar+B%22">Izar B</searchLink>; Columbia Center for Translational Immunology, New York, New York.; Columbia University Medical Center, Division of Hematology and Oncology, New York, New York.<br /><searchLink fieldCode="AU" term="%22Yuan+GC%22">Yuan GC</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wucherpfennig+KW%22">Wucherpfennig KW</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. kai&#95;wucherpfennig@dfci.harvard.edu.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2021 Apr; Vol. 9 (4), pp. 470-485. <i>Date of Electronic Publication: </i>2021 Jan 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33514509 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2326-6066.CIR-20-0085 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 470 Titles: – TitleFull: Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cartwright ANR – PersonEntity: Name: NameFull: Suo S – PersonEntity: Name: NameFull: Badrinath S – PersonEntity: Name: NameFull: Kumar S – PersonEntity: Name: NameFull: Melms J – PersonEntity: Name: NameFull: Luoma A – PersonEntity: Name: NameFull: Bagati A – PersonEntity: Name: NameFull: Saadatpour A – PersonEntity: Name: NameFull: Izar B – PersonEntity: Name: NameFull: Yuan GC – PersonEntity: Name: NameFull: Wucherpfennig KW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2021 Apr Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2326-6074 Numbering: – Type: volume Value: 9 – Type: issue Value: 4 Titles: – TitleFull: Cancer immunology research Type: main |
| ResultId | 1 |